298 related articles for article (PubMed ID: 37506572)
1. Curcumin and analogues against head and neck cancer: From drug delivery to molecular mechanisms.
Zhao C; Zhou X; Cao Z; Ye L; Cao Y; Pan J
Phytomedicine; 2023 Oct; 119():154986. PubMed ID: 37506572
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro effects of curcumin on head and neck carcinoma: a systematic review.
Borges GÁ; Rêgo DF; Assad DX; Coletta RD; De Luca Canto G; Guerra EN
J Oral Pathol Med; 2017 Jan; 46(1):3-20. PubMed ID: 27219631
[TBL] [Abstract][Full Text] [Related]
3. Curcumin analog, WZ37, promotes G2/M arrest and apoptosis of HNSCC cells through Akt/mTOR inhibition.
Zhang Z; Lin R; Liu Z; Yan T; Xia Y; Zhao L; Lin F; Zhang X; Li C; Wang Y
Toxicol In Vitro; 2020 Jun; 65():104754. PubMed ID: 31863822
[TBL] [Abstract][Full Text] [Related]
4. Curcumin Enhances the Efficacy of Docetaxel by Promoting Anti-Tumor Immune Response in Head and Neck Squamous Cell Carcinoma.
Sun L; Yao X; Liu J; Zhang Y; Hu J
Cancer Invest; 2023 May; 41(5):524-533. PubMed ID: 36946609
[TBL] [Abstract][Full Text] [Related]
5. Role of Vitamin D in Head and Neck Cancer-Immune Function, Anti-Tumour Effect, and Its Impact on Patient Prognosis.
Starska-Kowarska K
Nutrients; 2023 May; 15(11):. PubMed ID: 37299554
[TBL] [Abstract][Full Text] [Related]
6. Curcumin and analogues in mitigating liver injury and disease consequences: From molecular mechanisms to clinical perspectives.
Jiang Z; Liu L; Su H; Cao Y; Ma Z; Gao Y; Huang D
Phytomedicine; 2024 Jan; 123():155234. PubMed ID: 38042008
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma.
Lang L; Shay C; Zhao X; Xiong Y; Wang X; Teng Y
J Hematol Oncol; 2019 Dec; 12(1):132. PubMed ID: 31805962
[TBL] [Abstract][Full Text] [Related]
9. The roles of extracellular vesicles in the development, microenvironment, anticancer drug resistance, and therapy of head and neck squamous cell carcinoma.
Wang X; Guo J; Yu P; Guo L; Mao X; Wang J; Miao S; Sun J
J Exp Clin Cancer Res; 2021 Jan; 40(1):35. PubMed ID: 33478586
[TBL] [Abstract][Full Text] [Related]
10. A novel curcumin analog (H-4073) enhances the therapeutic efficacy of cisplatin treatment in head and neck cancer.
Kumar B; Yadav A; Hideg K; Kuppusamy P; Teknos TN; Kumar P
PLoS One; 2014; 9(3):e93208. PubMed ID: 24675768
[TBL] [Abstract][Full Text] [Related]
11. Combinatorial Effects of Curcumin with an Anti-Neoplastic Agent on Head and Neck Squamous Cell Carcinoma Through the Regulation of EGFR-ERK1/2 and Apoptotic Signaling Pathways.
Sivanantham B; Sethuraman S; Krishnan UM
ACS Comb Sci; 2016 Jan; 18(1):22-35. PubMed ID: 26505786
[TBL] [Abstract][Full Text] [Related]
12. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.
Wilken R; Veena MS; Wang MB; Srivatsan ES
Mol Cancer; 2011 Feb; 10():12. PubMed ID: 21299897
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the matrix metalloproteinase 9 (MMP9) inhibitor Andecaliximab as an Anti-invasive therapeutic in Head and neck squamous cell carcinoma.
Allen JL; Hames RA; Mastroianni NM; Greenstein AE; Weed SA
Oral Oncol; 2022 Sep; 132():106008. PubMed ID: 35803110
[TBL] [Abstract][Full Text] [Related]
14. Effect of Curcumin on the Head and Neck Squamous Cell Carcinoma Cell Line HN5.
Abdolahinia ED; Ahmadian S; Bohlouli S; Gharehbagh FJ; Jahandizi NG; Vahed SZ; Saadat YR; Aghbali A; Sharifi S; Dizaj SM; Alsharif KF; Khan H
Curr Mol Pharmacol; 2023; 16(3):374-380. PubMed ID: 35431006
[TBL] [Abstract][Full Text] [Related]
15. c-Src inhibitor PP2 inhibits head and neck cancer progression through regulation of the epithelial-mesenchymal transition.
Lee S; Park S; Ryu JS; Kang J; Kim I; Son S; Lee BS; Kim CH; Kim YS
Exp Biol Med (Maywood); 2023 Mar; 248(6):492-500. PubMed ID: 36527337
[TBL] [Abstract][Full Text] [Related]
16. New advances into cisplatin resistance in head and neck squamous carcinoma: Mechanisms and therapeutic aspects.
Hu H; Li B; Wang J; Tan Y; Xu M; Xu W; Lu H
Biomed Pharmacother; 2023 Jul; 163():114778. PubMed ID: 37137185
[TBL] [Abstract][Full Text] [Related]
17. Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane).
Chakravarti N; Myers JN; Aggarwal BB
Int J Cancer; 2006 Sep; 119(6):1268-75. PubMed ID: 16642480
[TBL] [Abstract][Full Text] [Related]
18. Anti-cancer effects of disulfiram in head and neck squamous cell carcinoma via autophagic cell death.
Park YM; Go YY; Shin SH; Cho JG; Woo JS; Song JJ
PLoS One; 2018; 13(9):e0203069. PubMed ID: 30212479
[TBL] [Abstract][Full Text] [Related]
19. Nanotechnology and curcumin: a novel and promising approach in digestive cancer therapy.
Zhang Y; Li Z; Huang Y; Xu Y; Zou B
Nanomedicine (Lond); 2023 Nov; 18(27):2081-2099. PubMed ID: 38078442
[TBL] [Abstract][Full Text] [Related]
20. Stimuli-responsive drug delivery systems for head and neck cancer therapy.
Liang J; Yang B; Zhou X; Han Q; Zou J; Cheng L
Drug Deliv; 2021 Dec; 28(1):272-284. PubMed ID: 33501883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
